So far, both the effects and the targets of EF in ischemic stroke have not been investigated, and our study demonstrated that EF could potently suppress microglia-mediated neuroinflammation by binding to MAO-B after ischemia, presenting a potential therapeutic compound in the treatment for ischemic stroke. This evidence concerns the gene MAOB and ischemia.